Discussion on Theory and Practice of Treating Multiple Myeloma Based on Shengma Biejia Decoction and Beating Chemotherapy Click Copy

Discussion on Theory and Practice of Treating Multiple Myeloma Based on Shengma Biejia Decoction and Beating Chemotherapy

《中国中医药信息杂志》[ISSN:1005-5304/CN:11-3519/R] Volume: 27卷 Issue: 2020年12期 Page: 123-125 Research Field: 经验交流 Publishing date: 2020-12-01
Title:
Discussion on Theory and Practice of Treating Multiple Myeloma Based on Shengma Biejia Decoction and Beating Chemotherapy
Author(s):
OU Tiantian1;  DAI Xingbin1;  SUN Xuemei2
1. Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China; 2. Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China
Keywords:
multiple myeloma;  dampness causes damage to bones;  Shengma Biejia Decoction;  beat ing chemotherapy ;  s tate adjustment
PACS:
R273.33
DOI:
10.19879/j.cnki.1005-5304.201901353
Abstract:
This article proposed that “dampness causes damage to bones”, and believed that dampness is the key pathological factor in the progression of multiple myeloma. The basic pathogenesis was dampness causing damaging to essence and blood and then to bones, which was closely related to heart and spleen. Therefore, the treatment method “dissipating dampness and eliminating toxic material, treating heart and spleen” was established. The medicine of insects, snakes , vines , etc. should be used flexibly, with some efficacy in clinic, which could contribute to enrich and expand the theoretical system of TCM for multiple myeloma.

References:

[1] 程纬民.多发性骨髓瘤骨病的中西医诊治进展[J].湖南中医杂志, 2015,31(5)：187-188.

[2] 代喜平,李达,梁冰.多发性骨髓瘤病因病机探微[J].浙江中西医结合杂志,2008,18(5)：290-292.

[3] MOSERLE L, CASANOVAS O. Anti-angiogenesis and metasts ais：a tumour and stromal cell alliance[J]. J Intern Med,2013,273(2)：128-137.

[4] PLATE K H, SCHOLZ A, DUMONT D J. Tumor angiogenesis and anti-angiogenic therapy in maligant gliomas revisited[J]. Acta Neuropathol,2012,124(6)：763-775.

[5] SHAKED Y, EMMENGGER U, MAN S, et al. Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity[J]. Blood,2005,106(9)：3058-3061.